covigen
Vaccineexperimental
Clinical trial activity
3 trials · 9 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Dec 31, 2020 (NCT04591184)
Timeline
2020s
- Jan 1, 2020
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- SARS-CoV-2Immunity, active
SARS-CoV-2 immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06436911 | Phase 1/Phase 2 (Phase 2) | Aug 31, 2024 | Entos Pharmaceuticals Inc., PCI Pharma Services, Q2 solutions |
| NCT04742842 | Phase 1 | Feb 15, 2021 | BioNet-Asia Co., Ltd., Technovalia, Telethon Kids Institute, University of Sydney |
| NCT04591184 | Phase 1 | Dec 31, 2020 | Canadian Institutes of Health Research (CIHR), Dalhousie University, Entos Pharmaceuticals Inc. |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (9)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Entos Pharmaceuticals Inc. | For profit | 2 | 2 | 2 | 2020 |
| BioNet-Asia Co., Ltd. | For profit | 1 | 0 | 1 | 2021 |
| Canadian Institutes of Health Research (CIHR) | Academic/Hospital | 1 | 0 | 1 | 2020 |
| Dalhousie University | Academic/Hospital | 1 | 0 | 1 | 2020 |
| PCI Pharma Services | For profit | 1 | 0 | 1 | 2024 |
| Q2 solutions | For profit | 1 | 0 | 1 | 2024 |
| Technovalia | For profit | 1 | 0 | 1 | 2021 |
| Telethon Kids Institute | Academic/Hospital | 1 | 0 | 1 | 2021 |
| University of Sydney | Academic/Hospital | 1 | 1 | 1 | 2021 |
9 organizations
Page 1 / 1